IMARC Group has recently released a new research study titled “US At-home Respiratory Care Services Market Size, Share, Trends and Forecast by Therapy, Indication, and Region, 2026-2034”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.



Market Overview

The US at-home respiratory care services market size was valued at USD 16,129.85 Million in 2025 and is projected to reach USD 32,416.02 Million by 2034, growing at a CAGR of 8.06% during 2026-2034. The market growth is driven by the shift towards home-based healthcare, adoption of value-based care models, and integration of digital health technologies enabling telehealth and remote patient monitoring. Demand is also supported by the aging population and the rise of chronic respiratory diseases like COPD, asthma, and sleep apnea. 

Study Assumption Years

  • Base Year: 2025

  • Historical Year/Period: 2020-2025

  • Forecast Year/Period: 2026-2034

US At-home Respiratory Care Services Market Key Takeaways

  • Current Market Size: USD 16,129.85 Million in 2025

  • CAGR: 8.06% during 2026-2034

  • Forecast Period: 2026-2034

  • The market benefits from the accelerating transition toward home-based healthcare delivery.

  • Value-based care models are transforming operational practices across home health agencies.

  • Digital health technologies such as telehealth and remote monitoring are quickly integrated.

  • Aging population and rising incidence of chronic respiratory diseases like COPD, asthma, and sleep apnea drive demand.

  • Medicare policies promoting home health services and efforts to reduce hospital readmissions further expand market share.

Sample Request Link: https://www.imarcgroup.com/us-at-home-respiratory-care-services-market/requestsample

US At-home Respiratory Care Services Market Growth Factors

The US at-home respiratory care services market growth is significantly influenced by the accelerating transition to home-based respiratory care delivery. This transformation, heightened post-COVID-19, is driven by patient preferences for comfort and infection risk reduction. Hospitals are increasingly referring high-acuity patients to home care, with 31% of home health referrals originating from hospitals in 2024. Technological advancements in portable medical devices facilitate safe administration of complex respiratory therapies at home, enhancing accessibility and clinical outcomes.

The widespread adoption of value-based care models is reshaping operational practices across home respiratory care providers. These models incentivize care quality and cost-effectiveness rather than service volume, encouraging investments in preventive services and remote monitoring technology. Notably, 70% of home care leaders reported major operational changes in 2023 due to value-based care implementation, including hiring care coordinators and developing data analytics capabilities. Over 60% of executives forecast that value-based contracts will generate at least half their income by 2027.

Integration of digital health technologies and remote patient monitoring is revolutionizing the sector. Remote monitoring platforms continuously track vital respiratory parameters, enabling early interventions before exacerbations escalate. AI-driven connected devices personalize patient care by learning baselines and alerting clinicians to abnormalities. Telehealth consultations complement this by offering convenient access to specialized care. Medicare’s expansion of reimbursements for remote patient monitoring and regulations supporting telehealth contribute to market growth. Collaborations like Modivcare and Tenovi’s integration of smart inhalers exemplify industry focus on digital health innovation.

To get more information on this market, Request Sample

US At-home Respiratory Care Services Market Segmentation

Breakup By Therapy:

  • Oxygen Therapy: Involves the provision of supplemental oxygen to patients at home, essential for managing chronic respiratory conditions.

  • Non-invasive Ventilation: Use of external ventilation devices that assist breathing without intubation, improving patient comfort and outcomes.

  • Sleep Apnea Care: Services related to diagnosis and treatment of sleep apnea, including home-based diagnostic devices and therapies.

  • Aerosol Therapy and Others: Includes delivery of medication as a mist inhaled into the lungs and other respiratory therapies administered at home.

Breakup  By Indication:

  • Chronic Obstructive Pulmonary Disease (COPD): Long-term respiratory disease segment driving demand for at-home therapeutic services.

  • Sleep Apnea (Obstructive and Central Types): Segment focusing on management and care of sleep apnea patients at home.

  • Asthma: Segment addressing chronic asthma care through at-home respiratory services and monitoring.

  • Post-acute Respiratory Failure: Care provided after acute respiratory failure episodes in home settings.

Breakup By Region:

  • Northeast

  • Midwest

  • South

  • West

The report provides detailed forecasts and trend analysis for all these regions.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=44003&flag=C

Recent Developments & News

  • January 2025: ResMed launched its FDA-cleared NightOwl home sleep apnea test nationwide in the US, enabling home-based diagnostic testing.

  • February 2024: ResMed introduced the AirCurve 11 series bilevel-positive airway pressure devices featuring integrated digital technology to improve therapy adherence for sleep apnea patients.

  • October 2024: Modivcare partnered with Tenovi to integrate Adherium's Hailie Smart Inhalers into its chronic condition management platform, enhancing medication adherence for severe asthma and other respiratory conditions.

Key Players

  • ResMed

  • Modivcare

  • Tenovi

  • Adherium

  • Philips Respironics (not currently selling in US due to FDA consent decree)

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

 

United States: +1-201971-6302